| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:09:46 UTC |
|---|
| Update date | 2019-11-26 03:05:14 UTC |
|---|
| Primary ID | FDB011672 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Safrole |
|---|
| Description | Occurs in nutmeg. Banned by FDA for use in food. Formerly used as a food flavour
It is a precursor in the synthesis of the insecticide synergist piperonyl butoxide and the recreational drug MDMA ("Ecstacy."); Safrole is a natural plant constituent, found in oil of sassafras and certain other essential oils. It is a member of the methylenedioxybenzene group of compounds, many of which (e.g. piperonyl butoxide) are extensively used as insecticide synergists. A major source of human exposure to safrole is through consumption of spices, such as nutmeg, cinnamon and black pepper, in which safrole is a constituent. Safrole is also present in root beer, and has been used as an additive in chewing gum, toothpaste, soaps and certain pharmaceutical preparations. Safrole is a weak hepatocarcinogen and it is a matter of considerable interest whether the ally1 moiety or the methylenedioxy group, or both, are involved in the mechanism of its carcinogenesis. Safrole is extensively metabolized, giving rise to a large number of metabolites. Metabolism involves essentially two major routes, oxidation of the ally1 side chain, and oxidation of the methylenedioxy group with subsequent cleavage to form the catechol. Safrole undergoes oxidation of the allylic group to yield the 2, 3-epoxide (safrole epoxide). The dihydrodiol is one of the metabolites of safrole, and presumably arises from the hydration of the 2, 3-epoxide. The principal route of metabolism of safrole is through cleavage of the methylenedioxy group, the major metabolites being allylcatechol and its isomer, propenylcatechol. Eugenol and its isomer I-methoxy- 2-hydroxy-4-allylbenzene have been detected as minor metabolites in the rat, mouse and man. (PMID: 6719936); Safrole, also known as shikimol, is a colorless or slightly yellow oily liquid. It is typically extracted from the root-bark or the fruit of sassafras plants in the form of sassafras oil, or synthesized from other related methylenedioxy compounds. It is the principal component of brown camphor oil, and is found in small amounts in a wide variety of plants, where it functions as a natural pesticide. The Ocotea cymbarum[verification needed] oil made of the Ocotea pretiosa[verification needed], a plant growing in Brazil, and sassafras oil made of Sassafras albidum, a tree growing in eastern North America, are the main natural sources for safrole. It has a characteristic "candy-shop" aroma. |
|---|
| CAS Number | 94-59-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 1,2-Methylenedioxy-4-allylbenzene | ChEBI | | 1-Allyl-3,4-methylenedioxybenzene | ChEBI | | 3,4-(Methylenedioxy)allylbenzene | ChEBI | | 3-(3,4-Methylenedioxyphenyl)prop-1-ene | ChEBI | | 4-Allyl-1,2-methylenedioxybenzene | ChEBI | | 4-Allylpyrocatechol formaldehyde acetal | ChEBI | | 5-(2-Propenyl)-1,3-benzodioxole | ChEBI | | 5-Allyl-benzo[1,3]dioxole | ChEBI | | Allylcatechol methylene ether | ChEBI | | m-Allylpyrocatechin methylene ether | ChEBI | | Safrol | ChEBI | | Shikimol | ChEBI | | Shikimole | ChEBI | | (1,2-(Methylenedioxy)-4-allyl)benzene | HMDB | | (Allyldioxy)benzene methylene ether | HMDB | | (e)5-1-Propenyl]-1,3-benzodioxole | HMDB | | 1, 2-(Methylenedioxy)-4-allylbenzene | HMDB | | 1,2-(Methylenedioxy)-4-propenylbenzene | HMDB | | 1,2-Methylenedioxy-4-allyl-benzene | HMDB | | 1-Allyl,3,4-methylenedioxy benzene | HMDB | | 3, 4-(Methylenedioxy)allylbenzene | HMDB | | 3,4-(Methylenedioxy)-1-propenylbenzene | HMDB | | 3,4-Methylenedioxy-allybenzene | HMDB | | 3,4-Methylenedioxyallylbenzene | HMDB | | 4-Allyl-1, 2-(methylenedioxy)benzene | HMDB | | 4-Allyl-1,2-(methylenedioxy)benzene, 8ci | HMDB | | 4-Allylpyrocatechol | HMDB | | 4-Propenyl-1,2-methylenedioxybenzene | HMDB | | 4-Propenylcatechol methylene ether | HMDB | | 5-(1-Propenyl)-1,3-benzodioxole | HMDB | | 5-(2-Propenyl)-1,3-benzodioxole, 9ci | HMDB | | 5-Allyl-1,3-benzodioxolerlet DS base | HMDB | | 5-Prop-2-enyl-1,3-benzodioxole | HMDB | | 6-(1-Propenyl)-1,3-benzodioxole | HMDB | | Allyldioxybenzene methylene ether | HMDB | | Allylpyrocatechol methylene ether | HMDB | | Isosafrol | HMDB | | Isosafrole | HMDB | | Izosafrol | HMDB | | Shikomol | HMDB | | 4 Allyl 1,2 methylenedioxybenzene | MeSH | | 4-Allyl-1,2-methylenedioxybenzenes | MeSH | | Safroles | MeSH | | Shikimols | MeSH | | Safrols | MeSH | | 4-Allyl-1,2-(methylenedioxy)benzene, 8CI | db_source | | 5-(2-Propenyl)-1,3-benzodioxole, 9CI | db_source | | 5-Allyl-1,3-benzodioxolerlet DS Base | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C10H10O2 |
|---|
| IUPAC name | 5-(prop-2-en-1-yl)-2H-1,3-benzodioxole |
|---|
| InChI Identifier | InChI=1S/C10H10O2/c1-2-3-8-4-5-9-10(6-8)12-7-11-9/h2,4-6H,1,3,7H2 |
|---|
| InChI Key | ZMQAAUBTXCXRIC-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | C=CCC1=CC2=C(OCO2)C=C1 |
|---|
| Average Molecular Weight | 162.1852 |
|---|
| Monoisotopic Molecular Weight | 162.068079564 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as benzodioxoles. These are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzodioxoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzodioxoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzodioxole
- Benzenoid
- Oxacycle
- Acetal
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: Environmental role: Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Liquid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 74.06%; H 6.21%; O 19.73% | DFC |
|---|
| Melting Point | Fp 11.2° | DFC |
|---|
| Boiling Point | Bp6 104-105° | DFC |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | n20D 1.5383 | DFC |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-0ik9-4900000000-9558c12b4c5a01a27490 | 2014-09-20 | View Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-3900000000-27e98ee529004a2d8b66 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-6900000000-54b4c1509456711936df | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-03di-6900000000-87b7efd770862a8f97a5 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-5900000000-0e7164aea8e5fa73ab55 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-03di-0900000000-cae3268c72651c72100c | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-3900000000-27e98ee529004a2d8b66 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-6900000000-54b4c1509456711936df | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-03di-6900000000-87b7efd770862a8f97a5 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-0ik9-5900000000-0e7164aea8e5fa73ab55 | Spectrum | | GC-MS | Safrole, non-derivatized, GC-MS Spectrum | splash10-03di-0900000000-cae3268c72651c72100c | Spectrum | | Predicted GC-MS | Safrole, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-01sa-2900000000-390702c1e607859e4700 | Spectrum | | Predicted GC-MS | Safrole, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-ce90b24b2ef83a609261 | 2016-08-02 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-1900000000-cb602c608751e483efce | 2016-08-02 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0udl-9600000000-85407378b64267759f6d | 2016-08-02 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0900000000-f5650e9b49b023a3cfd2 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-0900000000-9dbd3903283425175546 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-02ti-5900000000-4204c0caaf5bb9b5d258 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-9b0c6d7bc981d77b1927 | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03k9-0900000000-01530378eccaf5c845f0 | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0fvr-9400000000-d251b0867c3f55c2e90e | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0900000000-4d3d221c51bdf4e740a2 | 2021-09-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-0900000000-3a92a79dc10e1183839f | 2021-09-25 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-01ot-7900000000-1024f7dba32bfc58ce37 | 2021-09-25 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 90 MHz, CDCl3, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 25.16 MHz, CDCl3, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 13848731 |
|---|
| ChEMBL ID | CHEMBL242273 |
|---|
| KEGG Compound ID | C10490 |
|---|
| Pubchem Compound ID | 5144 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB33591 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | GXV45-I:GXV45-I |
|---|
| EAFUS ID | 3354 |
|---|
| Dr. Duke ID | SAFROLE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00002771 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | 94-59-7 |
|---|
| GoodScent ID | rw1010791 |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anesthetic | | A drug that induces a reversible loss of sensation, used to prevent pain and discomfort during medical procedures, surgeries, and diagnostic tests, promoting patient comfort and facilitating treatment. | DUKE | | Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE | | Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti convulsant | 52217 | An agent that reduces or prevents seizures, commonly used in managing epilepsy, neuropathic pain, and mood disorders, by stabilizing abnormal electrical activity in the brain. | DUKE | | Anti septic | 33281 | An agent that prevents or reduces the growth of microorganisms, such as bacteria, fungi, or viruses, to promote wound healing and prevent infection. Therapeutically, anti septics are used to treat minor cuts, scrapes, and burns, and are commonly applied topically to reduce the risk of infection and promote tissue repair. Key medical uses include wound care, surgical site preparation, and skin infection management. | DUKE | | Calcium antagonist | 48706 | A medication that blocks calcium ion entry into cells, reducing muscle contraction and vascular resistance. It treats hypertension, angina, and arrhythmias by dilating blood vessels and decreasing cardiac workload, commonly used in managing cardiovascular diseases. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Carcinogenic | 50903 | An agent that causes cancer, damaging cellular DNA and disrupting normal cell growth. It has no therapeutic applications, but understanding its biological role informs cancer prevention and treatment strategies, with key medical uses in oncology research and risk assessment. | DUKE | | Carminative | | An agent that prevents or relieves gas in the gastrointestinal tract, facilitating its expulsion and combating flatulence, commonly used to soothe digestive issues and alleviate symptoms of bloating and discomfort. | DUKE | | Central nervous system depressant | 35470 | An agent that slows brain activity, reducing anxiety, stress, and excitability. Therapeutically, it's used to manage insomnia, seizures, and anxiety disorders, promoting relaxation and sedation. Key medical uses include treating insomnia, epilepsy, and panic disorders, as well as inducing anesthesia. | DUKE | | Central nervous system stimulant | 35470 | An agent that increases alertness and activity by enhancing neurotransmitter release, used therapeutically to manage attention deficit hyperactivity disorder (ADHD), narcolepsy, and fatigue, and to improve cognitive function and mood. | DUKE | | Controlled | | A substance or behaviour regulated by external factors, such as laws or medical supervision. Its biological role involves moderation of potentially harmful activities. Therapeutically, controlled substances have applications in pain management and addiction treatment. Key medical uses include managing chronic pain, anxiety, and insomnia, while minimizing abuse and dependence risks. | DUKE | | Cytochrome-p450 inducer | | An agent that stimulates cytochrome-p450 enzyme activity, enhancing drug metabolism. Therapeutically, it increases clearance of toxic substances and certain medications, with applications in managing drug interactions, toxic exposures, and some cancers. | DUKE | | Cytochrome-p488 inducer | | An agent that stimulates the activity of cytochrome-p488 enzymes, enhancing drug metabolism and detoxification. Therapeutically, it aids in managing drug interactions and toxicity, with potential applications in cancer treatment and pharmacokinetic enhancement. | DUKE | | DNA-binder | | An agent that binds to DNA, regulating gene expression and replication. It has therapeutic applications in gene therapy, cancer treatment, and antimicrobial therapy, with key medical uses including targeting viral DNA and modulating immune responses. | DUKE | | Hepatocarcinogenic | 50903 | An agent that promotes the development of liver cancer, having a harmful biological role. It has no therapeutic applications, but understanding its effects is crucial in liver cancer research and prevention. Key medical uses include studying liver carcinogenesis and developing strategies to mitigate its harmful effects. | DUKE | | Hepatoregenerative | 62868 | An agent that promotes liver regeneration and repair, supporting the biological role of liver tissue restoration. It has therapeutic applications in treating liver diseases, such as cirrhosis and hepatitis, and key medical uses include enhancing liver function and reducing liver damage. | DUKE | | Hepatotoxic | 50908 | An agent that causes liver damage or toxicity, disrupting normal liver function. It has no therapeutic applications, but is often a side effect of certain medications, such as acetaminophen overdose, and is a key consideration in medical uses, including monitoring liver function during drug therapy. | DUKE | | Hypothermic | | A condition of abnormally low body temperature, playing a biological role in reducing metabolic rate and oxygen demand. Therapeutically, it has applications in neuroprotection, cardiac surgery, and trauma care. Key medical uses include treating heatstroke, cardiac arrest, and brain injuries, as well as preserving organs for transplantation. | DUKE | | Irritant | | An agent that causes slight inflammation or discomfort, stimulating a biological response. Therapeutically, it can be used to increase blood flow or stimulate healing. Key medical uses include treating wounds, skin conditions, and respiratory issues, such as congestion, by inducing a mild inflammatory response to promote recovery. | DUKE | | Mutagenic | | An agent that induces genetic mutations, altering DNA sequences. It plays a biological role in evolution and adaptation. Therapeutically, mutagenic agents are used in cancer treatment, such as chemotherapy, and in gene therapy to introduce beneficial traits. Key medical uses include oncology and genetic research. | DUKE | | Nematicide | 25491 | An agent that kills nematodes, a type of parasitic worm, used to control infestations in crops and animals, with therapeutic applications in veterinary medicine to treat parasitic infections and promote livestock health. | DUKE | | Neurotoxic | 50910 | A substance that damages or destroys nerve cells, disrupting normal brain function. It has no therapeutic applications, but is used in research to study neurodegenerative diseases. Key medical uses include understanding and developing treatments for conditions like Alzheimer's and Parkinson's diseases, where neurotoxicity plays a role. | DUKE | | Pediculicide | 38706 | An agent that kills lice, used to treat infestations such as head lice, body lice, and pubic lice, reducing discomfort and preventing the spread of diseases like typhus and trench fever. | DUKE | | Perfumery | 48318 | The art of creating fragrances, playing a biological role in emotional and sensory stimulation. Therapeutically, perfumery has applications in aromatherapy, reducing stress and anxiety. Key medical uses include mood enhancement, pain management, and promoting relaxation, with certain scents exhibiting anti-anxiety and anti-depressant properties. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Psychoactive | 35471 | A substance that affects brain function, altering mood, perception, or consciousness. It plays a biological role in modifying neurotransmitter activity. Therapeutically, psychoactive substances have applications in managing mental health disorders, such as depression and anxiety. Key medical uses include treating psychiatric conditions, including attention deficit hyperactivity disorder (ADHD), and certain sleep disorders. | DUKE | | Tremorigenic | | An agent that induces tremors, causing involuntary muscle contractions and relaxation, often used in research to study movement disorders, with potential therapeutic applications in neurology and psychiatry, particularly in managing conditions like Parkinson's disease and essential tremor. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| spice |
- Arn, H, Acree TE. “Flavornet: A database of aroma compounds based on odor potency in natural products”. Developments in Food Science 40 (1998): 27. doi:10.1016/S0167-4501(98)80029-0
| | sweet |
- Arn, H, Acree TE. “Flavornet: A database of aroma compounds based on odor potency in natural products”. Developments in Food Science 40 (1998): 27. doi:10.1016/S0167-4501(98)80029-0
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | warm |
- Arn, H, Acree TE. “Flavornet: A database of aroma compounds based on odor potency in natural products”. Developments in Food Science 40 (1998): 27. doi:10.1016/S0167-4501(98)80029-0
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | spicy |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | woody |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | floral |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | sassafrass |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | anise |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|